Redmile Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-262,400
| Closed | -$6M | – | 87 |
|
|
2018
Q2 | $6M | Sell |
262,400
-72,280
| -22% | -$1.65M | 0.2% | 59 |
|
|
2018
Q1 | $9.52M | Sell |
334,680
-84,000
| -20% | -$2.39M | 0.37% | 51 |
|
|
2017
Q4 | $8.84M | Buy |
418,680
+36,409
| +10% | +$769K | 0.38% | 52 |
|
|
2017
Q3 | $6.95M | Sell |
382,271
-316,121
| -45% | -$5.74M | 0.34% | 50 |
|
|
2017
Q2 | $10.8M | Buy |
698,392
+16,500
| +2% | +$256K | 0.66% | 44 |
|
|
2017
Q1 | $11.8M | Sell |
681,892
-15,100
| -2% | -$261K | 0.76% | 44 |
|
|
2016
Q4 | $7.66M | Sell |
696,992
-17,700
| -2% | -$195K | 0.66% | 34 |
|
|
2016
Q3 | $11.2M | Sell |
714,692
-19,207
| -3% | -$301K | 0.89% | 30 |
|
|
2016
Q2 | $7.5M | Buy |
733,899
+4,200
| +0.6% | +$42.9K | 0.72% | 34 |
|
|
2016
Q1 | $9.41M | Sell |
729,699
-8,657
| -1% | -$112K | 0.96% | 26 |
|
|
2015
Q4 | $14.4M | Buy |
+738,356
| New | +$14.4M | 1.08% | 27 |
|